What Serum Institute's persistence on Oxford vaccine trials means for India

The company is going ahead regardless of AsraZeneca pausing trials in UK after an adverse impact was reported

On Tuesday AstraZeneca voluntarily suspended clinical trials in the UK for the University of Oxford-developed vaccine candidate after an event of potential adverse side effect came to notice. The Indian arm of the trials continues its process. A lot is riding on what is dubbed as one of the frontrunners for Covid-19 vaccine. A look at what it means for India and Serum Institute: 

Why was the AstraZeneca-Oxford University trial paused?

British-Swedish drug major AstraZeneca on Tuesday decided to halt clinical trials of AZD1222, a vaccine candidate developed by the University of Oxford, after a participant fell sick with an